• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Granzymes / Related Products
You are here: Product Lines > Inflammation > Granzymes / Related Products
Toolbar - View Selection
 
 Items 20-30 of 30 Page 2 of 2 Select Page: << 1 2   
ALX-804-135 Revised 26-Feb-07
Monoclonal Antibody to Perforin (CE2.10)
Add to Clipboard
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Perforin / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-804-135-C100   100 µg 290.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
Mouse
CLONE: CE2.10
ISOTYPE: Mouse IgG2a
CONCENTRATION: 1mg/ml
FORMULATION: Liquid. In PBS containing 0.02% sodium azide.
IMMUNOGEN: Recombinant mouse perforin (aa 98-534).
SPECIFICITY: Recognizes an epitope in the region aa 402-534 of human and mouse perforin.
APPLICATION: Immunoprecipitation (human and mouse)
Western Blot (mouse only)
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: +4°C
USE/STABILITY: Stable for at least 6 months after receipt when stored at +4°C undiluted.
HANDLING: Do not freeze/thaw.
Product Images
Please click on thumbnails to enlarge.
General Information
MANUFACTURER Manufactured by Apotech Corporation.
Further Categories Containing This Product:
Monoclonal Antibodies
 
 
ALX-804-057 Revised 03-Apr-06
Monoclonal Antibody to Perforin (mouse) (CB5.4)
Add to Clipboard
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Perforin / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-804-057-C100 Purified 100 µg 290.00 USD Add To Cart
ALX-804-057F-T100 FITC 100 tests 350.00 USD Add To Cart
ALX-804-057TD-T100 ATTO 488 100 tests 360.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Mouse
CLONE: CB5.4
ISOTYPE: Rat IgG2a
CONCENTRATION: 1mg/ml
PURITY: ≥95% (SDS-PAGE)
FORMULATION: Liquid. In PBS containing 0.02% sodium azide.
IMMUNOGEN: Recombinant mouse perforin (aa 98-534).
SPECIFICITY: Recognizes mouse perforin (region aa 402-534).
APPLICATION: CB5.4-Purified:
Immunocytochemistry
Immunohistochemistry (frozen sections, paraffin sections)
Immunoprecipitation
Western Blot
CB5.4-ATTO 488:
Immunocytochemistry
CB5.4-FITC:
Immunocytochemistry
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
USE/STABILITY: Stable for at least 6 months after receipt when stored at +4°C.
HANDLING: For long term storage keep unconjugated antibody at -20°C. Avoid freeze/thaw cycles. Keep ATTO, Biotin- and FITC-conjugated formats at +4°C. Do not freeze. Protect from light.
Product Images
Please click on thumbnails to enlarge.
Product Description
New ATTO-fluorescent antibodies show increased photostability, outstanding brightness and intense signals. ATTO dyes are thermally stable, resistant to environmental changes and show no significant isomerization. ATTO 488 shows bright green fluorescence (λabs (max): 501nm, λem (max): 523nm, εmax: 90’000).
Product Specific Literature References
The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes: M. Dupuis, et al.; J. Exp. Med. 177, 1 (1993) Abstract
Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin: C. Muller & J. Tschopp; J. Immunol. 153, 2470 (1994) Abstract
Cubilin, a binding partner for galectin-3 in the murine utero-placental complex: S. Crider-Pirkle, et al.; J. Biol. Chem. 277, 15904 (2002) Abstract; Full Text
Fas-Fas Ligand Interactions Are Essential for the Binding to and Killing of Activated Macrophages by {gamma}{delta} T Cells: J.E. Dalton, et al.; J. Immunol. 173, 3660 (2004) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION CB5.4-FITC: 1 test means: 1µl of a 1mg/ml stock solution were used to stain 200’000 cells in a sample volume of 50µl.
MANUFACTURER Manufactured by Apotech Corporation.
General Literature References
Cubilin, a binding partner for galectin-3 in the murine utero-placental complex: S. Crider-Pirkle, et al.; J. Biol. Chem. 277, 15904 (2002) Abstract
Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells: J.E. Dalton, et al.; J. Immunol. 173, 3660 (2004) Abstract
Further Categories Containing This Product:
Monoclonal Antibodies
 
 
ALX-804-595 Revised 16-Jul-07
Monoclonal Antibody to Proteinase Inhibitor 9 (human) (7D8)
Add to Clipboard
SYNONYMS anti-PI9 (human) MAb (7D8)
anti-Serpin B9 (human) MAb (7D8)
anti-CAP3 (human) MAb (7D8)
anti-Cytoplasmic Antiproteinase 3 (human) MAb (7D8)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Proteinase Inhibitor 9
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-804-595-C100   100 µg 280.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
CLONE: 7D8
ISOTYPE: Mouse IgG1
CONCENTRATION: 1mg/ml
FORMULATION: Liquid. In PBS containing 0.05% sodium azide.
IMMUNOGEN: Recombinant PI9 (proteinase inhibitor 9).
SPECIFICITY: Recognizes human PI9. Does not cross-react with mouse or pig PI9.
APPLICATION: Flow Cytometry
Immunohistochemistry (frozen sections; paraffin sections require antigen retrieval using heat treatment methods prior to staining)
Western Blot
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: +4°C
USE/STABILITY: Stable for 12 months when stored at +4°C.
Product Specific Literature References
Perforin-independent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction: C.E. Hirst, et al.; Mol. Hum. Reprod. 7, 1133 (2001) Abstract; Full Text
The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency: C.E. Hirst, et al.; J. Immunol. 170, 805 (2003) Abstract
General Information
The human intracellular serpin proteinase inhibitor 9 (PI9) is the only human protein able to inhibit the activity of the serine protease granzyme B. Granzyme B is expressed by cytotoxic lymphocytes and induces rapid target cell apoptosis. 
General Literature References
Human proteinase inhibitor 9 (PI9) is a potent inhibitor of subtilisin A: J.R. Dahlen, et al.; BBRC 238, 329 (1997) Abstract
Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway: C.H. Bird, et al.; Mol. Cell. Biol. 18, 6387 (1998) Abstract
Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9: R.R. Annand, et al.; Biochem. J. 342 Pt 3, 655 (1999) Abstract; Full Text
Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9: J.R. Dahlen, et al.; Biochim. Biophys. Acta 1451, 233 (1999) Abstract
Further Categories Containing This Product:
Monoclonal Antibodies
 
 
ALX-804-457 Revised 07-Oct-08
Monoclonal Antibody to Proteinase Inhibitor 9 (human) (PI9-17)
Add to Clipboard
SYNONYMS anti-PI9 (human) MAb (PI9-17)
anti-Serpin B9 (human) MAb (PI9-17)
anti-CAP3 (human) MAb (PI9-17)
anti-Cytoplasmic Antiproteinase 3 (human) MAb (PI9-17)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Proteinase Inhibitor 9
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-804-457-C125   125 µg 350.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
CLONE: PI9-17
ISOTYPE: Mouse IgG1
CONCENTRATION: ~250µg/ml
FORMULATION: Liquid. In serum free culture supernatant containing 0.7% BSA and 0.1% sodium azide.
IMMUNOGEN: Recombinant human full-length PI9 (proteinase inhibitor 9).
SPECIFICITY: Recognizes human PI9. Detects bands of ~42kDa (native PI9) and ~67kDa (PI9 complexed to granzyme B) by Western blot. Does not cross-react with PI6, PI8 or PAI-2.
APPLICATION: Immunohistochemistry (formaldehyde-fixed paraffin-embedded human tissues after pretreatment with 10mM citric acid pH 6.0 for 20min (use ~1:100). For fixed cytospin preparations fix cells for 10 min in 10% formalin and then treat them as paraffin sections).
Western Blot (standard procedures).
Not suitable for flow cytometry.
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
Product Images
Please click on thumbnails to enlarge.
Product Specific Literature References
The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites: B.A. Bladergroen, et al.; J. Immunol. 166, 3218 (2001) Abstract; Full Text
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?: B.A. Bladergroen, et al.; Blood 99, 232 (2002) Abstract; Full Text
Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9: P. Kannan-Thulasiraman & D.J. Shapiro; J. Biol. Chem. 277, 41230 (2002) Abstract; Full Text
General Information
The human intracellular serpin proteinase inhibitor 9 (PI9) is the only human protein able to inhibit the activity of the serine protease granzyme B. Granzyme B is expressed by cytotoxic lymphocytes and induces rapid target cell apoptosis. 
General Literature References
Human proteinase inhibitor 9 (PI9) is a potent inhibitor of subtilisin A: J.R. Dahlen, et al.; BBRC 238, 329 (1997) Abstract
Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway: C.H. Bird, et al.; Mol. Cell. Biol. 18, 6387 (1998) Abstract
Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9: R.R. Annand, et al.; Biochem. J. 342 Pt 3, 655 (1999) Abstract; Full Text
Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9: J.R. Dahlen, et al.; Biochim. Biophys. Acta 1451, 233 (1999) Abstract
Further Categories Containing This Product:
Monoclonal Antibodies
 
 
ALX-200-604/1 Revised 04-Jun-08
Perforin (human)
Add to Clipboard
SYNONYMS Lymphocyte Pore Forming Protein (human)
PFP (human)
Cytolysin (human)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Perforin / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-200-604/1-C001   1 µg 450.00 USD Add To Cart
Product Specification
MW: ~70kDa
SOURCE/HOST: Human cytotoxic granules of YT cells.
CONCENTRATION:  
PURITY DETAIL: Purified by solubilization in 1M sodium chloride (sodium acetate buffer) followed by hydrophobic interaction chromatography.
FORMULATION: Liquid. In 150mM NaCl containing stabilizer.
SPECIFIC ACTIVITY: 5-10PU (permeabilizing units) (Jurkat)/µg protein. One PU is defined as the amount of perforin (ng) that produces 50% PI-positive cells in the sample.
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
USE/STABILITY:

The stock solution may be diluted 10-fold with the provided dilution buffer. Prepare aliquots and store at -80°C. Diluted aliquots are stable for up to 3 months when stored at -80°C and for ~12 hours when stored at +4°C.

HANDLING: Avoid freeze/thaw cycles. For maximum product recovery after thawing, centrifuge the vial before opening the cap.
Product Specific Literature References
Granzyme B binds to target cells mostly by charge and must be added at the same time as perforin to trigger apoptosis: L. Shi, et al.; J. Immunol. 174, 5456 (2005) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION

Swiss-Prot link P14222: Perforin 1 (human) (precursor)

General Note:

Both primary and transformed lines are permeabilized by the perforin, but the concentration required to produce 50% permeabilized cells varies substantially according to cell type (e.g. lymphoid, epithelial, mesenchymal), sensitivity of the cell line and whether cells are suspended or adherent. Generally, consumption of perforin is greater in the testing of adherent cells due to non-specific binding of the pore-forming protein to the microwells. Perforin should be pre-titrated against the desired cell line to identify the minimal permeabilizing concentration for protein delivery (see below). This concentration will allow effective delivery of the protein without producing excessive background necrosis and represent the nanograms that achieve less than 10-20% permeabilization of the target cell in question.

Supplied with Perforin Dilution Buffer (1ml).


Protocol for Intracellular Perforin Mediated Protein Delivery

a. Materials Needed:
- Microfuge tubes (1.5ml)
- Calcium stock solution: 100mM CaCl2 in water.
- Ca2+-HEPES buffer: 20mM HEPES containing 150mM NaCl and 2.5mM CaCl2, pH 7.4
- BSA-HEPES buffer: 1% BSA solubilized in HEPES buffer (without Ca2+).
- Fatty acid-free BSA.
- Perforin Dilution Buffer (included).

b. Pre-titration of PFN against Desired Cells:
Immediately before the planned experiment, perforin should be titrated to identify concentration that minimally permeabilizes targets. Incubate desired cells with increasing concentrations of perforin for 15 min., then determine percentage of cells that have undergone permeabilization by Trypan Blue or Propidium Iodide stain.
1) Wash cells twice in Ca2+-HEPES buffer to remove serum from cell mixture and re-suspend at density
    of 1x106 per 50µl in same buffer.
2) For each sample, dilute perforin to twice the desired final concentration in 50µl of HEPES/1% BSA
    buffer to microfuge tubes.
3) Add 50µl of media control or dilute perforin to 50µl of cells in microfuge tubes.
4) Incubate at 37°C for 15 min.; periodic mixing is not required.
5) Perform readout to assess permeabilization.

d. Experimental Protocol:
1) Wash cells twice in Ca2+-HEPES buffer to remove serum from cell mixture and re-suspend at density
    of 1x106 per 50µl in same buffer.
2) Add Granzyme B (Prod. No. ALX-200-602) (1µg/ml); generally 1-2µl of stock is sufficient.
3) For desired samples, dilute perforin to twice the desired final concentration in 50µl of HEPES/1% BSA
    buffer to microfuge tubes.
4) Add 50µl of media control or dilute perforin to 50µl of cells in microfuge tubes.
5) Incubate at 37°C for desired time; periodic mixing is not required.
6) After incubation perform readout to assess permeabilization.

Further Categories Containing This Product:
Natural Proteins
 
 
ALX-210-917 Revised 02-Nov-06
Polyclonal Antibody to SET (human)
Add to Clipboard
SYNONYMS anti-PHAPII (human) PAb
anti-I2αPP2A (human) PAb
anti-Phosphatase 2A Inhibitor Protein 2α (human) PAb
anti-HLA-DR-associated Protein 2 (human) PAb
anti-IGAAD (human) PAb
anti-Inhibitor of Granzyme-activated DNase (human) PAb
anti-TAF-Iβ (human) PAb
anti-Template-activating Factor Iβ (human) PAb
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY PP2A / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-210-917-C050   50 µg 194.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
SOURCE/HOST: From rabbit.
CONCENTRATION: 1mg/ml
PURITY DETAIL: Protein A affinity-purified.
FORMULATION: Liquid. In PBS containing 0.02% sodium azide.
IMMUNOGEN: Synthetic peptide corresponding to aa 3-16 (A3PAAKVSKKELNSN16) of human SETβ.
SPECIFICITY: Recognizes human SETβ. Detects endogenous protein by IP and WB.
APPLICATION: Flow cytometry (1:100-1:200);
Immunocytochemistry;
Immunoprecipitation;
Western blot (1:1'000).
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
USE/STABILITY: Stable for at least one year after receipt if stored at -20°C.
HANDLING: Avoid freeze/thaw cycles.
Product Specific Literature References
Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks: P.J. Beresford, et al.; J. Biol. Chem. 276, 43285 (2001) Abstract; Full Text
HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A: Z. Fan, et al.; Mol. Cell. Biol. 22, 2810 (2002) Abstract; Full Text
Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A: Z. Fan, et al.; Nat. Immunol. 4, 145 (2003) Abstract
Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor: Z. Fan, et al.; Cell 112, 659 (2003) Abstract
Granzyme a induces caspase-independent mitochondrial damage, a required first step for apoptosis: D. Martinvalet, et al.; Immunity 22, 355 (2005) Abstract
General Information
MANUFACTURER Manufactured by Apotech Corporation.
Further Categories Containing This Product:
Granzymes Other ProductsPolyclonal Antibodies
 
 
ALX-260-153 Revised 07-Nov-05
Z-AAD-CMK (Ready-to-Use)
Add to Clipboard
SYNONYMS Granzyme B Inhibitor (Ready-to-Use)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Caspase Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-260-153-R020 10mM 20 µl 175.00 USD Add To Cart
Product Specification
SEQUENCE: Z-Ala-Ala-Asp-chloromethylketone
MW: 441.9
CONCENTRATION: 10mM
PURITY: ≥96% (HPLC)
FORMULATION: Liquid. In DMSO.
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
Product Description
Synthetic peptide that irreversibly inhibits granzyme B activity. The inhibitor is desigend as a methyl ester to facilitate cell permeability.
Further Categories Containing This Product:
Granzyme Inhibitors
 
 
ALX-260-073 Revised 20-Aug-07
Z-IE(OMe)TD(OMe)-FMK
Add to Clipboard
SYNONYMS Caspase-8 Inhibitor (Fluoromethylketone)
Granzyme B Inhibitor (Fluoromethylketone)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Caspase Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-260-073-M001   1 mg 220.00 USD Add To Cart
ALX-260-073-M005   5 mg 660.00 USD Add To Cart
Product Specification
SEQUENCE: Z-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone
FORMULA: C30H43FN4O11
MW: 654.7
PURITY: ≥90% (HPLC)
APPEARANCE: White to off-white solid.
SOLUBILITY: Soluble in DMSO.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
USE/STABILITY: Store stock solutions in aliquots at -20°C.
HANDLING: Packaged under inert gas.
Product Description
Irreversible, cell permeable inhibitor of caspase-8 and granzyme B. Inhibits also caspase-10.
Product Specific Literature References
Role of caspases in immunotoxin-induced apoptosis of cancer cells: A. Keppler-Hafkemeyer, et al.; Biochemistry 37, 16934 (1998) Abstract
Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal: D.A. Martin, et al.; J. Biol. Chem. 273, 4345 (1998) Abstract; Full Text
Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide: E.A. Sweeney, et al.; FEBS Lett. 425, 61 (1998) Abstract
Caspase-mediated proteolysis and activation of protein kinase Cδ plays a central role in neutrophil apoptosis: A. Khwaja & L. Tatton; Blood 94, 291 (1999) Abstract; Full Text
Reconstitution of caspase-8 sensitizes JB6 cells to TRAIL: I.K. Kim, et al.; BBRC 277, 311 (2000) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION We recommend a final concentration of 2µM for inhibiting caspase activity in Jurkat cell culture. The optimal doses may vary for different cells and culture conditions.
Further Categories Containing This Product:
Granzyme Inhibitors
 
 
ALX-260-144 Revised 01-Sep-05
Z-IETD-FMK (Ready-to-Use)
Add to Clipboard
SYNONYMS Caspase-8 Inhibitor (Fluoromethylketone) (Ready-to-Use)
Granzyme B Inhibitor (Fluoromethylketone) (Ready-to-Use)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Caspase Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-260-144-R100 2mM 100 µl 161.00 USD Add To Cart
ALX-260-144-R020 10mM 20 µl 161.00 USD Add To Cart
Product Specification
SEQUENCE: Z-Ile-Glu-Thr-Asp-fluoromethylketone
MW: 654.0
PURITY: ≥99% (HPLC)
FORMULATION: Liquid. In DMSO.
SHIPPING: SHIPPED ON BLUE ICE
LONG TERM STORAGE: -20°C
Product Description
Irreversible, cell permeable inhibitor of caspase-8 and granzyme B. Inhibits also caspase-10.
General Information
BACKGROUND/TECHNICAL INFORMATION W